세계의 저분자 표적 치료 시장 보고서(2025년)

Small molecule targeted therapy consists of low-molecular-weight drugs that specifically interact with disease-related targets such as enzymes, receptors, or signaling proteins. These therapies selectively inhibit or modulate disease pathways, enabling precise treatment while minimizing effects on healthy cells.

The primary therapy types of small molecule targeted therapy are chemotherapy, targeted therapy, and immunotherapy. Chemotherapy involves the use of chemical drugs to kill rapidly dividing cells in the body. Key drug classes, including monoclonal antibodies, small molecule inhibitors, and combination therapies, act through mechanisms such as kinase inhibition, proteasome inhibition, aromatic hydrocarbon receptor modulation, and cell cycle inhibition. This therapy is applied in conditions such as cancer, autoimmune diseases, and infectious diseases and can be administered orally, intravenously, or subcutaneously.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The small molecule targeted therapy market research report is one of a series of new reports from The Business Research Company that provides small molecule targeted therapy market statistics, including small molecule targeted therapy industry global market size, regional shares, competitors with a small molecule targeted therapy market share, detailed small molecule targeted therapy market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule targeted therapy industry. This small molecule targeted therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule targeted therapy market size has grown strongly in recent years. It will grow from $70.45 billion in 2024 to $77.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period was driven by the expanding availability of advanced diagnostic tools, increasing number of clinical trials, heightened focus on oncology and rare disease treatments, growing regulatory approvals for innovative small molecule drugs, and rising emphasis on combination therapies.

The small molecule targeted therapy market size is expected to see strong growth in the next few years. It will grow to $110.52 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth during the forecast period is fueled by increasing prevalence of chronic and genetic diseases, greater adoption of personalized medicine, growing investment in pharmaceutical research and development, rising awareness among healthcare professionals and patients, and higher government support and funding. The primary trends in the forecast period include technological advancements in drug design, progress in high-throughput screening techniques, development of precision medicine platforms, technology-driven improvements in drug delivery systems, and integration of genomics and proteomics data.

The increasing focus on personalized medicine is anticipated to drive growth in the small molecule targeted therapy market. Personalized medicine is a healthcare strategy that customizes prevention, diagnosis, and treatment based on an individual's genetic, environmental, and lifestyle factors. This growing shift toward personalized approaches is largely fueled by advancements in genomics, which have enabled a deeper understanding of genetic variations and facilitated the development of more precise, targeted treatments that enhance patient outcomes and minimize trial-and-error in therapies. Small molecule targeted therapy contributes to personalized medicine by specifically targeting a patient's unique molecular or genetic disease profile, improving treatment efficacy and reducing side effects. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a significant increase from six in 2022. These approvals included seven cancer drugs and three for other conditions, underscoring the role of personalized medicine in driving growth in the small molecule targeted therapy market.

Companies in the small molecule targeted therapy market are focusing on creating innovative oral solutions to improve targeted drug delivery, enhance patient compliance, and address specific molecular pathways, especially in oncology and chronic diseases. Oral small molecules are low-molecular-weight drugs designed to be taken by mouth, which can easily enter cells and target disease-related proteins or pathways. For instance, in June 2025, Kura Oncology Inc., a biotech company based in the US, received FDA approval for its New Drug Application (NDA) for ziftomenib, an oral treatment for adult patients with relapsed or refractory acute myeloid leukemia (AML) with nucleophosmin 1 (NPM1) mutations. This oral targeted therapy addresses a critical unmet need for adult AML patients with NPM1 mutations, offering a favorable safety profile and promising efficacy, including significant complete remission rates in clinical trials. Ziftomenib works by selectively inhibiting the menin-KMT2A interaction, disrupting leukemic cell growth and providing a new treatment option for this difficult-to-treat subtype of AML.

In May 2025, Eli Lilly and Company, a US-based pharmaceutical firm, acquired SiteOne Therapeutics Inc. for an undisclosed amount. The acquisition strengthens Eli Lilly's chronic pain treatment portfolio by adding innovative, non-addictive therapies targeting chronic pain through advanced sodium channel inhibitors. SiteOne Therapeutics Inc., also based in the US, specializes in small molecule targeted therapies.

Major players in the small molecule targeted therapy market are F. Hoffmann-La Roche AG (Roche), Merck KGaA, Pfizer Inc., Bayer AG, Sanofi S.A., Novartis International AG, AstraZeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, Blueprint Medicines Corporation, Kura Oncology Inc., G1 Therapeutics Inc., Ascentage Pharma Group International Inc., Rgenta Therapeutics Inc., Verastem Inc.

North America was the largest region in the small molecule targeted therapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in small molecule targeted therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the small molecule targeted therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule targeted therapy market consists of sales of tyrosine kinase inhibitors, proteasome inhibitors, and BCL-2 inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Targeted Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule targeted therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule targeted therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The small molecule targeted therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Therapy: Chemotherapy; Targeted Therapy; Immunotherapy
• 2) By Drug Class: Monoclonal Antibodies; Small Molecule Inhibitors; Combination Therapies
• 3) By Mechanism Of Action: Kinase Inhibitors; Proteasome Inhibitors; Aromatic Hydrocarbon Receptor (Ahr) Modulators; Cell Cycle Inhibitors
• 4) By Disease Indication: Cancer; Autoimmune Diseases; Infectious Diseases
• 5) By Route Of Administration: Oral; Intravenous; Subcutaneous
• Subsegments:
• 1) By Chemotherapy: Alkylating Agents; Antimetabolites; Anti-microtubule Agents
• 2) By Targeted Therapy: Kinase Inhibitors; Proteasome Inhibitors; Aromatic Hydrocarbon Receptor (AhR) Modulators
• 3) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines; Monoclonal Antibodies
• Companies Mentioned: F. Hoffmann-La Roche AG (Roche); Merck KGaA; Pfizer Inc.; Bayer AG; Sanofi S.A.; Novartis International AG; AstraZeneca PLC; Bristol-Myers Squibb Company; GlaxoSmithKline plc (GSK); Eli Lilly and Company; Amgen Inc.; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Lonza Group AG; Blueprint Medicines Corporation; Kura Oncology Inc.; G1 Therapeutics Inc.; Ascentage Pharma Group International Inc.; Rgenta Therapeutics Inc.; Verastem Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Targeted Therapy Market Characteristics

3. Small Molecule Targeted Therapy Market Trends And Strategies

4. Small Molecule Targeted Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Small Molecule Targeted Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Small Molecule Targeted Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Small Molecule Targeted Therapy Market Growth Rate Analysis
• 5.4. Global Small Molecule Targeted Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Small Molecule Targeted Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Small Molecule Targeted Therapy Total Addressable Market (TAM)

6. Small Molecule Targeted Therapy Market Segmentation

• 6.1. Global Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• 6.2. Global Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Small Molecule Inhibitors
• Combination Therapies
• 6.3. Global Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kinase Inhibitors
• Proteasome Inhibitors
• Aromatic Hydrocarbon Receptor (Ahr) Modulators
• Cell Cycle Inhibitors
• 6.4. Global Small Molecule Targeted Therapy Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Autoimmune Diseases
• Infectious Diseases
• 6.5. Global Small Molecule Targeted Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.6. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anti-microtubule Agents
• 6.7. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kinase Inhibitors
• Proteasome Inhibitors
• Aromatic Hydrocarbon Receptor (AhR) Modulators
• 6.8. Global Small Molecule Targeted Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immune Checkpoint Inhibitors
• Cancer Vaccines
• Monoclonal Antibodies

7. Small Molecule Targeted Therapy Market Regional And Country Analysis

• 7.1. Global Small Molecule Targeted Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Small Molecule Targeted Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Small Molecule Targeted Therapy Market

• 8.1. Asia-Pacific Small Molecule Targeted Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Small Molecule Targeted Therapy Market

• 9.1. China Small Molecule Targeted Therapy Market Overview
• 9.2. China Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Small Molecule Targeted Therapy Market

• 10.1. India Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Small Molecule Targeted Therapy Market

• 11.1. Japan Small Molecule Targeted Therapy Market Overview
• 11.2. Japan Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Small Molecule Targeted Therapy Market

• 12.1. Australia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Small Molecule Targeted Therapy Market

• 13.1. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Small Molecule Targeted Therapy Market

• 14.1. South Korea Small Molecule Targeted Therapy Market Overview
• 14.2. South Korea Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Small Molecule Targeted Therapy Market

• 15.1. Western Europe Small Molecule Targeted Therapy Market Overview
• 15.2. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Small Molecule Targeted Therapy Market

• 16.1. UK Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Small Molecule Targeted Therapy Market

• 17.1. Germany Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Small Molecule Targeted Therapy Market

• 18.1. France Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Small Molecule Targeted Therapy Market

• 19.1. Italy Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Small Molecule Targeted Therapy Market

• 20.1. Spain Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Small Molecule Targeted Therapy Market

• 21.1. Eastern Europe Small Molecule Targeted Therapy Market Overview
• 21.2. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Small Molecule Targeted Therapy Market

• 22.1. Russia Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Small Molecule Targeted Therapy Market

• 23.1. North America Small Molecule Targeted Therapy Market Overview
• 23.2. North America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Small Molecule Targeted Therapy Market

• 24.1. USA Small Molecule Targeted Therapy Market Overview
• 24.2. USA Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Small Molecule Targeted Therapy Market

• 25.1. Canada Small Molecule Targeted Therapy Market Overview
• 25.2. Canada Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Small Molecule Targeted Therapy Market

• 26.1. South America Small Molecule Targeted Therapy Market Overview
• 26.2. South America Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Small Molecule Targeted Therapy Market

• 27.1. Brazil Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Small Molecule Targeted Therapy Market

• 28.1. Middle East Small Molecule Targeted Therapy Market Overview
• 28.2. Middle East Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Small Molecule Targeted Therapy Market

• 29.1. Africa Small Molecule Targeted Therapy Market Overview
• 29.2. Africa Small Molecule Targeted Therapy Market, Segmentation By Type Of Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Small Molecule Targeted Therapy Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Small Molecule Targeted Therapy Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Small Molecule Targeted Therapy Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule Targeted Therapy Market Competitive Landscape
• 30.2. Small Molecule Targeted Therapy Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG (Roche) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Small Molecule Targeted Therapy Market Other Major And Innovative Companies

• 31.1. Novartis International AG
• 31.2. AstraZeneca PLC
• 31.3. Bristol-Myers Squibb Company
• 31.4. GlaxoSmithKline plc (GSK)
• 31.5. Eli Lilly and Company
• 31.6. Amgen Inc.
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Astellas Pharma Inc.
• 31.9. Lonza Group AG
• 31.10. Blueprint Medicines Corporation
• 31.11. Kura Oncology Inc.
• 31.12. G1 Therapeutics Inc.
• 31.13. Ascentage Pharma Group International Inc.
• 31.14. Rgenta Therapeutics Inc.
• 31.15. Verastem Inc.

32. Global Small Molecule Targeted Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Small Molecule Targeted Therapy Market

34. Recent Developments In The Small Molecule Targeted Therapy Market

35. Small Molecule Targeted Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Small Molecule Targeted Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Small Molecule Targeted Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Small Molecule Targeted Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer